MarketInOut Stock Screener Log In | Sign Up
 

Nyxoah S.A.

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
Nyxoah S.A. stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization84.98 mln
Float81.29 mln
Earnings Date11/05/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-1.35
Manipulation likely

1-Year Forecast

3.72
Transformational upside

Relative Strength

4 / 100
Severely lagging

Debt / Equity

0.72
Moderate leverage

Pre-Tax Margin

-436%
Severely loss-making

Business Description

Founded in Belgium in 2009, Nyxoah SA focuses on improving the lives of people who suffer from moderate to severe obstructive sleep apnea. Its flagship product, the Genio system, stimulates a nerve in the tongue to keep the airway open during sleep, requiring only a small surgical procedure. The device has received CE Mark approval, reflecting its safety and effectiveness for patients across Europe.

Key Fundamentals

EPS-2.56
ROE-164
RPS0.44
ROIC-109
ROA-80.73
Interest Cover-5.73
EBITDA, mln-95.94
EV / EBITDA-0.28
EV / EBIT-0.26
Revenue, mln25.25
EV / Revenue1.05

Quote Details

Last 0.8344
Change 0.0124 (1.51%)
Open 0.8627
Volume 181,006
Turnover 151,031
Average Volume 236,750

Financial Ratios

Pre-Tax Profit Margin-436
Leverage Ratio2.03
Current Ratio2.37
Price / Book1.49
Price / Tangible Book3.51
Debt / Equity0.72
Price / Sales2.61

Financial Strength

Altman Z-Score-3.08
Piotroski F-Score 3 / 9
Beneish M-Score-1.35
1-Year Target Price3.72
Short Ratio0.57
Short % of Float0.36

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -24.83% 2 / 100   
1 Month -34.3% 9 / 100   
2 Months -46.51% 9 / 100   
6 Months -72% 6 / 100   
1 Year -85.49% 7 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog